Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ICON plc - Ordinary Shares (NQ:ICLR)

150.84 -0.98 (-0.65%)
Streaming Delayed Price Updated: 12:06 PM EDT, Jun 10, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ICON plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
The Clinical Crisis: A Deep-Dive Into ICON plc (ICLR) Amidst a Transformational Storm
Date: February 12, 2026 Introduction ICON plc (NASDAQ: ICLR) currently finds itself at a pivotal and precarious crossroads. As the world’s second-largest Clinical Research Organization (CRO), the... 
Via Finterra
Topics Artificial Intelligence Fraud Lawsuit
Stay updated with the stocks that are on the move in today's pre-market session. ↗
Via Chartmill
ICLR Stock Crashed 33% In Pre-Market Today - Why Did The Company Withdraw Its FY2025 Guidance? ↗
Via Stocktwits
News headline image
ICON plc Provides Update on Timing of Fourth Quarter and Full Year 2025 Earnings Results and Investigation into Accounting Practices
From ICON plc
Via Business Wire
ICON PLC (NASDAQ:ICLR) Presents a Compelling Value Investment Case ↗
Via Chartmill
News headline image
Trinity Street Sells $22 Million of Axalta Coating Systems Stock ↗
Axalta Coating Systems serves global automotive and industrial markets with specialty coatings and a diverse product lineup. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
ICON’s Accellacare Site Network Expands Oncology Research Capabilities With New Cancer Institute Partnership
From ICON plc
Via Business Wire
News headline image
Backbone of Discovery: A Deep Dive into Charles River Laboratories (CRL)
In the complex ecosystem of modern medicine, few companies carry as much institutional weight—or stir as much controversy—as Charles River Laboratories International, Inc. (NYSE: CRL). As of December... 
Via PredictStreet
Topics Animal Testing Artificial Intelligence Economy
News headline image
What Analysts Are Saying About Icon Stock ↗
 
Via Benzinga
News headline image
ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive
From ICON plc
Via Business Wire
News headline image
ICON Survey Reveals Increasing Clinical Trial Startup Delays, Underscoring Need for Human-Centred Site Activation Solutions
From ICON plc
Via Business Wire
News headline image
Warren Buffett Disciple Seth Klarman Takes New Stake In Railroad Company, Lowers Stake In This Magnificent Seven Stock ↗
Baupost Group, led by Seth Klarman, made major changes to its investment portfolio in the third quarter. A look at the changes. 
Via Benzinga
News headline image
ICON plc to Present at the Jefferies London Healthcare Conference
From ICON plc
Via Business Wire
News headline image
6 Analysts Assess Icon: What You Need To Know ↗
 
Via Benzinga
News headline image
ICON PLC (NASDAQ:ICLR) Reports Mixed Q3 2025 Results with Revenue Beat and Guidance Cut ↗
ICON PLC's Q3 2025 results show a mixed quarter with a slight revenue beat but an EPS miss. Shares fell as the company lowered its full-year guidance due to sector headwinds. 
Via Chartmill
News headline image
ICON Reports Third Quarter 2025 Results
From ICON plc
Via Business Wire
News headline image
Earnings Scheduled For October 22, 2025 ↗
 
Via Benzinga
News headline image
Examining the Future: Icon's Earnings Outlook ↗
 
Via Benzinga
News headline image
ICON PLC (NASDAQ:ICLR): A Value Investing Case Study ↗
ICON PLC (ICLR) presents a strong value investing case with attractive P/E ratios, solid profitability, and stable financial health, suggesting potential undervaluation. 
Via Chartmill
News headline image
ICON plc Schedules Third Quarter 2025 Earnings Conference Call
From ICON plc
Via Business Wire
News headline image
11 Analysts Assess Icon: What You Need To Know ↗
 
Via Benzinga
News headline image
ICON Announces CEO Transition
From ICON plc
Via Business Wire
News headline image
ICON plc to Participate at Upcoming Investor Conferences
From ICON plc
Via Business Wire
News headline image
3 Healthcare Pathbreakers With Long-Term Tailwinds ↗
These three firms in the fast-changing healthcare sector stand out to analysts for their strong product lineups, defensible technology, and notable pipelines. 
Via MarketBeat
News headline image
Assessing Icon: Insights From 8 Financial Analysts ↗
 
Via Benzinga
News headline image
ICON PLC (NASDAQ:ICLR) Presents a Compelling Value Investment Opportunity with Strong Fundamentals ↗
ICON PLC (ICLR) is a value stock with strong valuation metrics, solid profitability, and stable financials, trading below industry averages. A potential undervalued opportunity for investors. 
Via Chartmill
News headline image
Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? ↗
Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance. 
Via Benzinga
Topics Earnings
News headline image
ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery ↗
ICON lifts its 2025 revenue forecast, beats booking targets in Q2 and expands its share buyback plan as market conditions remain variable. 
Via Benzinga
News headline image
RPM International Posts Better-Than-Expected Earnings, Joins ICON, MaxLinear, Nasdaq And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Thursday's session: gap up and gap down stocks ↗
Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.